Business Description
CB Scientific Inc
NAICS : 621511
SIC : 8071
ISIN : US12506E1038
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.18 | |||||
Equity-to-Asset | -1.92 | |||||
Debt-to-Equity | -0.08 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -72.56 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 87.34 | |||||
9-Day RSI | 68.74 | |||||
14-Day RSI | 57.6 | |||||
6-1 Month Momentum % | -60.26 | |||||
12-1 Month Momentum % | -60.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.27 | |||||
Quick Ratio | 0.24 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 4197.5 | |||||
Days Sales Outstanding | 10.29 | |||||
Days Payable | 14819 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -9.65 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.46 | |||||
Operating Margin % | -1602.31 | |||||
Net Margin % | -1585.39 | |||||
FCF Margin % | -663.08 | |||||
ROA % | -848.85 | |||||
ROIC % | -571.94 | |||||
ROC (Joel Greenblatt) % | -8800 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 62 | |||||
EV-to-EBIT | -4.07 | |||||
EV-to-EBITDA | -4.07 | |||||
EV-to-Revenue | 66.14 | |||||
EV-to-FCF | -9.97 | |||||
Earnings Yield (Greenblatt) % | -24.57 | |||||
FCF Yield % | -9.82 |